URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS
The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Slovenian |
Published |
26.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides compounds of Formula I
or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors . |
---|---|
AbstractList | The present invention provides compounds of Formula I
or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors . |
Author | HUDKINS Robert L DANDU Reddeppareddy JOSEF Kurt A PROUTY Catherine P TRIPATHY Rabindranath |
Author_xml | – fullname: PROUTY Catherine P – fullname: HUDKINS Robert L – fullname: TRIPATHY Rabindranath – fullname: DANDU Reddeppareddy – fullname: JOSEF Kurt A |
BookMark | eNrjYmDJy89L5WQwDQ1ydPb0UXBxDfIMcwzxDHMNVnAEoggfBUc_FwVnXV_XEAVvTz_HYFcFTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDo5hri7KGbWpAfn1pckJicmpdaEh_saWRuYWBsbBESYmhMjBoA1wspnA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | URACILNI DERIVATI KOT ZAVIRALCI AXL IN C-MET KINAZE |
ExternalDocumentID | SI2780338TT1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_SI2780338TT13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:55:08 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Slovenian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_SI2780338TT13 |
Notes | Application Number: SI20120030843 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170426&DB=EPODOC&CC=SI&NR=2780338T1 |
ParticipantIDs | epo_espacenet_SI2780338TT1 |
PublicationCentury | 2000 |
PublicationDate | 20170426 |
PublicationDateYYYYMMDD | 2017-04-26 |
PublicationDate_xml | – month: 04 year: 2017 text: 20170426 day: 26 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | Ignyta, Inc |
RelatedCompanies_xml | – name: Ignyta, Inc |
Score | 3.0838087 |
Snippet | The present invention provides compounds of Formula I
or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170426&DB=EPODOC&locale=&CC=SI&NR=2780338T1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwjSt-K2rh97KNKlHYts3VizsbeRpikMZBuu4r_vpW7qi0IeQgKX5OBy-eVyvwA8Wm4rF15HmU5mKbMtM2kKYUvTyy3ppbJhiS-2z9jpT9svc3tegeU-F6bkCf0oyRHRoiTae1Hu15ufS6ywfFu5fUqX2LR-7nE_NHbouOlqSGCEXT8aj8IRNSj1E2bEE7_leg1EYxyB0oE-RWua_WjW1Ukpm98epXcKh2MUtirOoLJ9rcEx3X-8VoOj4S7ejdWd6W3PwZ5OAsoGJETkNQs4m0UJCbDMBySIQ0LNYcQJYvEgiQiL-6zL-GiSXMBDL-K0b-L4i--1LhK2nylvWpdQXa1X6gpIZuWq2RHCzVXadhxbaKaxTLlennfwACOvof63nPp_nTdwovWmAyQt5xaqxdu7ukM_W6T3pYY-AWzjfg0 |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_Ejbm3zW1M95XB6FuZWvvhQxk1rTRbrWKj-CZpmoIwVGbH_v0lnW572SAPIYFLcnC5_HK5XwAeDLuTM6cndCszhN7lGdcZM7nu5AZ3Ut4y2BfbZ2yF0-7z3JxXYLnPhSl5Qj9KckRpUVzae1Hu15ufSyy_fFu5fUyXsmn9NKCur-3QcdtWkEDz-24wHvkjrGHsJkSLJ27HdloSjVEJlA5sRc6rTk6zvkpK2fz2KIMTOBxLYaviFCrb1zrU8P7jtTocDXfxblndmd72DMzpxMMkQr5EXjOPklmQIE-WeYS82EdYHwYUSSzuJQEicUj6hI4myTncDwKKQ12Ov_he6yIh-5nStnEB1dV6JS4BZUYu2j3G7FykXcsymWIay4Tt5HlPHmB4A5p_y2n-13kHtZAOo0VE4pcrOFY6VMGSjnUN1eLtXdxIn1ukt6W2PgF6DID6 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=URACIL+DERIVATIVES+AS+AXL+AND+C-MET+KINASE+INHIBITORS&rft.inventor=PROUTY+Catherine+P&rft.inventor=HUDKINS+Robert+L&rft.inventor=TRIPATHY+Rabindranath&rft.inventor=DANDU+Reddeppareddy&rft.inventor=JOSEF+Kurt+A&rft.date=2017-04-26&rft.externalDBID=T1&rft.externalDocID=SI2780338TT1 |